Skip to main content
. 2014 Mar 31;32(13):1309–1316. doi: 10.1200/JCO.2013.51.4240

Fig 5.

Fig 5.

Mixed-model repeated-measures analysis for the Functional Assessment of Cancer Therapy–Ovarian Cancer Symptom Index. Estimates for the between-treatment group comparison for each time point and for the entire profile were obtained. The estimates are presented with the corresponding 95% CIs in parentheses. BEV, bevacizumab; CT, chemotherapy.